We are live on ! Find out more
DWA

Dorsey Wright & Associates Portfolio holdings

AUM $590M
1-Year Est. Return 77.57%
This Fund
S&P 500
This Quarter Est. Return
+19.64%
1 Year Est. Return
+77.57%
3 Year Est. Return
+310.64%
5 Year Est. Return
10 Year Est. Return
AUM
$677M
AUM Growth
+$123M
Cap. Flow
+$38.6M
Cap. Flow %
5.7%
Top 10 Hldgs %
39.23%
Holding
420
New
123
Increased
125
Reduced
47
Closed
119

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$45.2M
2
CHE icon
Chemed
CHE
+$6M
3
AU icon
AngloGold Ashanti
AU
+$5.79M
4
ZTO icon
ZTO Express
ZTO
+$5.04M
5
MA icon
Mastercard
MA
+$5.02M

Sector Composition

Rank Sector Weight
1 Technology 15.31%
2 Healthcare 9.94%
3 Consumer Discretionary 8.86%
4 Industrials 8.17%
5 Materials 7.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COWN
251
DELISTED
Cowen Inc. Class A Common Stock
COWN
$14K ﹤0.01%
+535
New +$12.1K
ARLO icon
252
Arlo Technologies
ARLO
$1.54B
$13K ﹤0.01%
+1,716
New +$10.4K
CLDX icon
253
Celldex Therapeutics
CLDX
$3.35B
$13K ﹤0.01%
+760
New +$13.7K
CULP icon
254
Culp Inc
CULP
$43.2M
$13K ﹤0.01%
+800
New +$11.4K
IDT icon
255
IDT Corp
IDT
$1.67B
$13K ﹤0.01%
+1,078
New +$11.9K
INOD icon
256
Innodata
INOD
$2.03B
$13K ﹤0.01%
+2,450
New +$9.74K
INVE icon
257
Identive
INVE
$64.1M
$13K ﹤0.01%
+1,534
New +$10.6K
JYNT icon
258
The Joint Corp
JYNT
$119M
$13K ﹤0.01%
+477
New +$10.9K
KALV
259
DELISTED
KalVista Pharmaceuticals
KALV
$13K ﹤0.01%
+700
New +$12K
LCUT icon
260
Lifetime Brands
LCUT
$220M
$13K ﹤0.01%
+886
New +$11.1K
LYTS icon
261
LSI Industries
LYTS
$912M
$13K ﹤0.01%
1,518
+380
+33% +$2.93K
PACK icon
262
Ranpak Holdings
PACK
$479M
$13K ﹤0.01%
+987
New +$10.9K
SNDX icon
263
Syndax Pharmaceuticals
SNDX
$1.7B
$13K ﹤0.01%
+600
New +$12.4K
TITN icon
264
Titan Machinery
TITN
$420M
$13K ﹤0.01%
+660
New +$11.3K
TPB icon
265
Turning Point Brands
TPB
$1.73B
$13K ﹤0.01%
+300
New +$11.3K
TWI icon
266
Titan International
TWI
$438M
$13K ﹤0.01%
+2,639
New +$10.8K
HZN
267
DELISTED
Horizon Global Corporation
HZN
$13K ﹤0.01%
+1,460
New +$10.4K
HYRE
268
DELISTED
HyreCar Inc. Common Stock
HYRE
$13K ﹤0.01%
+1,834
New +$10K
SRLP
269
DELISTED
SPRAGUE RESOURCES LP
SRLP
$13K ﹤0.01%
709
+177
+33% +$3.02K
SHSP
270
DELISTED
SharpSpring, Inc.
SHSP
$13K ﹤0.01%
+769
New +$10.7K
TPCO
271
DELISTED
Tribune Publishing Company Common Stock
TPCO
$13K ﹤0.01%
+980
New +$12.1K
AGX icon
272
Argan
AGX
$7.84B
$12K ﹤0.01%
259
+65
+34% +$2.92K
BGFV
273
DELISTED
Big 5 Sporting Goods
BGFV
$12K ﹤0.01%
+1,174
New +$10.4K
CLFD icon
274
Clearfield
CLFD
$390M
$12K ﹤0.01%
501
+125
+33% +$2.93K
DLHC icon
275
DLH Holdings
DLHC
$68.7M
$12K ﹤0.01%
+1,236
New +$11.6K

Similar funds

Dorsey Wright & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Dorsey Wright & Associates held 420 positions worth $677M, up 22% from $555M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Dorsey Wright & Associates deployed $38.6M of net new capital in Q4 2020, opening 123 new positions and adding to 125 existing holdings. Its largest new stake was iShares Morningstar Small-Cap Growth ETF: 1,362,486 shares worth $68.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $45.2M trimmed.

  • Dorsey Wright & Associates's largest Q4 2020 buy was iShares Morningstar Small-Cap Growth ETF: 1,362,486 shares worth $68.9M.
  • Dorsey Wright & Associates added most to iShares Morningstar Mid-Cap Growth ETF in Q4 2020, an estimated $8.76M increase.
  • Dorsey Wright & Associates's biggest Q4 2020 reduction was Invesco QQQ Trust, cutting an estimated $45.2M.
  • Dorsey Wright & Associates fully exited Chemed in Q4 2020, selling an estimated $6M.
  • Dorsey Wright & Associates's ten largest holdings make up 39% of its $677M portfolio in Q4 2020.
  • Dorsey Wright & Associates opened 123 new positions and closed 119 in Q4 2020.
  • Dorsey Wright & Associates's portfolio value rose 22% quarter-over-quarter to $677M.

Based on Dorsey Wright & Associates's 13F filing for Q4 2020, filed 28 Jan 2021.